Objective: Heart and renal diseases are two major problems in diabetic patients. Hyperlipidemia is one of the main risk factors of cardiovascular complications in diabetes. The type of protein consumed also affects the changes in renal blood flow, glomerular resistance and renal function in these patients. Hence, this study was undertaken to show the effect of soy protein consumption on lipid profiles and kidney function of diabetic patients with nephropathy, who attended an educational university hospital as well as a private kidney disease clinic in Tehran. Subjects and methods: This crossover randomized clinical trial was conducted on 14 patients who were free of any uncontrolled condition or other renal diseases. The patients were asked to follow a usual nephropathy diet (0.8 g/kg protein, 70% animal and 30% vegetable protein) for 7 weeks. After a washout period of 4 weeks consuming the prestudy diet, subjects were readmitted to repeat the same cycle with a similar diet containing 35% soy protein and 30% vegetable protein. Paired ttest, carryover effect and period effect were used for statistical analysis. Result: There were 10 men and four women whose mean (s.d.) of weight was 70.6 (10.3) kg. Significant reductions were seen in total cholesterol (Po0.01), triglyceride (Po0.002) and LDL-c (Po0.04), urinary urea nitrogen and proteinuria (Po0.001) after soy vs animal protein consumption. There were no significant changes in HDL-c, LDL-c/HDL-c levels. We also saw a favorable effect on renal function. Conclusion: Soy inclusion in the diet can modify the risk factors of heart disease and improve kidney function in these patients.
Introduction
Diabetes is the fourth leading cause of death by disease and is the primary contributor to blindness, heart and kidney disease. Clinical research spanning the last 40 years documents the fact that diabetic subjects may have increased renal plasma flow, glomerular hyperfiltration, decreased vascular resistance and hyperlipidemia (Green et al, 1999) . Hyperlipidemia is one of the main risk factors associated with the high prevalence of cardiovascular complications in diabetes with nephropathy. Dietary intervention has traditionally been implemented in the treatment of diabetes and amelioration of kidney disease. A usual prescribed diet for nephropathy has 0.8 g/kg body weight with 70% of animal protein. This diet may be accompanied by other side effects like increased blood cholesterol and atherosclerosis (Joana et al, 1998) . Clinical trials on human subjects have found that not only the quantity of protein but also the type of protein has important implications in renal disease. The 'soy protein hypothesis' suggests that substitution of soy protein for animal protein in diabetic patients results in modifying the lipid indices and glomerular hypertension, therefore protecting against diabetic nephropathy. As little as 25 g of soy protein per day can contribute to a reduction in serum lipids. This reduction in cholesterol is beneficial in the etiology of renal disease. Oxidation of LDL-c may promote glomerular injury. Soy protein not only offers benefits by itself but also prevents further damage induced by animal protein. So the source of protein can have an impact on kidney disease (Green et al, 1999) . In previous studies on diabetes, patients consumed only vegetable protein in their diet and it was incompatible. The aim of this study is to determine the effect of dietary soy protein consumption as a part of dietary protein on lipid indices and renal function in type II diabetic patients with nephropathy who were attended to in an educational hospital as well as a private kidney disease clinic in Tehran.
Patients and methods

Subjects
A total of 14 patients, who were free of any uncontrolled conditions or other renal disease, were recruited in this study. All subjects had proteinuria with total urine protein excretion between 300 and 1000 mg/day, serum creatinine between 1 and 2.5 mg/dl and blood urea nitrogen between 20 and 40 mg/dl. Their systolic and diastolic blood pressure was more than 140 and 90 mmHg, respectively.
Experimental protocol
In this crossover randomized clinical trial, the patients were asked to follow a diet containing 0.8 g/kg protein (70% animal and 30% vegetable protein) for 7 weeks (Jibani et al, 1991) . After a washout period of 4 weeks consuming the prestudy diet, subjects were readmitted to repeat the same cycle while consuming a similar diet with 0.8 g/kg protein containing 35% soy protein, 30% vegetable protein and 35% animal protein. Both diets had 2000 mg sodium, 2000 mg potassium and 1500 mg phosphorus. A 24-h dietary recall was completed every 2 weeks and anthropometric indices were assessed. Hematological values and renal function were evaluated at the beginning, and after 7, 11 and 18 weeks of the study. Laboratory assessments included fasting serum lipids (cholesterol, triacylglycerols, HDL-c, calculated LDL-c), fasting blood sugar, glycohemoglobin, urine and serum creatinine, proteinuria, blood and urinary urea nitrogen, serum calcium phosphorus, potassium, sodium and GFR (Burtis & Edward, 1996) .
Statistics
Analysis of consumed foods was carried out by the Nutritionist III program, and statistical analysis was performed by using the Statistical Package for Social Science (SPSS Inc., Version 10.0). Baseline and treatment values were compared by the paired t-test. Change scores (final-initial) for animal and soy protein were compared by two-way t-tests. Carryover effect and period effect were tested (Fliess, 1986) .
Results
There were 10 men (71.5%) and four women (28.5%) in this study. Mean (7s.d.) of weight and age were 70.6 (710.3) kg and 62.5 (712.1) y, respectively. A comparison of the effect of soy and animal protein on blood lipid indices is shown in Table 1 . The amounts of dietary nutrient intake are illustrated in Table 2 . There were no significant changes in anthropometric indices, drug dosage, physical activity level, blood pressure and glycemic indices during the study. Significant reduction was seen in proteinuria, urinary urea 
Discussion
The results showed that soy protein had a beneficiary effect on serum lipid profile and renal function. After soy consumption, total cholesterol decreased significantly, in agreement with another study in which subjects consumed a diet with 50% of soy protein (Anderson et al, 1998) . As a result of lower intake of saturated fatty acids during the soy period, we had anticipated this reduction in total cholesterol. However, only 35% of dietary protein was from soy protein, triglyceride reduced significantly, and as this is one of the greatest benefits of soy consumption on lipid profiles, we concluded that this amount of soy might have beneficial effects. The changes in serum triacylglycerol were substantially greater than nondiabetic subjects reported in the literature (Anderson et al, 1995; Nilavsen & Meinertz, 1998) . Amico and Gentile (1993) also mentioned this effect of soy. LDL-c reduction is probably the most important effect of soy consumption in these patients, because high levels of LDL-c can play an important role in the etiology of cardiovascular disease. The isoflavones in soy protein can also play a key role in modifying lipid profiles (Potter et al, 1998) . So the results of laboratory tests may be attributed to isoflavones of this protein.
The effect of flavonoid-rich foodstuffs on cholesterol metabolism was tested recently in animals and humans. In rabbits with experimental hypercholesterolemia induced by a casein-based, semipurified diet in which drinking water was replaced with either orange juice or grapefruit juice, serum LDL-c decreased by 43 and 32%, respectively (Kurowska et al, 2000) . So, according to these favorable effects of soy protein on lipid profile, we conclude that this protein can have a protective effect against heart disease. Despite these beneficiary effects of soy on serum lipid concentrations, there is some evidence that reports no significant changes in serum lipid level after soy protein intake. In Soroka et al's (1998) study, total cholesterol, LDL-c, triglyceride did not change, which might be because of patient conditions and the existence of next to normal levels of baseline cholesterol, LDL, triglyceride. However, Wong et al (1998) showed that the hypocholesterolemic effect of soy protein was found to be independent of age, body weight, pretreatment plasma lipid concentrations and sequence of dietary treatment. After soy consumption, urinary urea nitrogen reduced, which was also mentioned in Soroka et al's research. There were no significant reductions in urinary urea nitrogen in Jibani et al's intervention, which might be because of a lower amount of soy protein intake. The significant reduction that was seen in proteinuria in this study could be attributed to reduction of glomerular filtration rate, intraluminal pressure and increased glomerular resistance. The different results in different studies could contribute to the different amounts of protein consumption and the existence of patients in different stages of nephropathy. As a result of reduction in urinary urea nitrogen and proteinuria, it is estimated that soy protein intake could improve renal function in these patients. This point is noticeable in kidney disease also. Although soy-protein intake may effectively decrease the hyperfiltration that antedates the onset of proteinuria in type I and type II diabetes, it may not protect from the hypertensive damage to the kidneys that commonly occurs in type II diabetes patients. No significant changes in blood pressure may be related to resistant glomerular injury (Krummel, 2000) . As hyperlipidemia can impair the renal vascular resistance and permeability, the observed improvement in proteinuria may contribute to improvement of lipid profiles (Anderson et al, 1998) . Mulec et al (1990) also mentioned the association between hypercholesterolemia and diabetic nephropathy. So soy protein intake may also have a favorable effect on diabetic nephropathy through reductions in serum lipid levels (Dobois et al, 1994; Anderson et al, 1998) . It can be concluded that consumption of a diet with soy protein can modify the risk factors of heart disease and renal function in these patients.
